{"id":"https://openalex.org/W2033728841","doi":"https://doi.org/10.1016/j.ejps.2009.09.004","title":"Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats","display_name":"Triple verses glimepiride plus metformin therapy on cardiovascular risk biomarkers and diabetic cardiomyopathy in insulin resistance type 2 diabetes mellitus rats","publication_year":2009,"publication_date":"2009-09-17","ids":{"openalex":"https://openalex.org/W2033728841","doi":"https://doi.org/10.1016/j.ejps.2009.09.004","mag":"2033728841","pmid":"https://pubmed.ncbi.nlm.nih.gov/19765654"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejps.2009.09.004","doi":"https://doi.org/10.1016/j.ejps.2009.09.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2009.09.004","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030922510","display_name":"Ashish Kumar Sharma","orcid":"https://orcid.org/0000-0003-0742-8555","observed_orcids":["https://orcid.org/0000-0003-0742-8555"]},"institutions":[{"id":"https://openalex.org/I91894341","display_name":"Gyan Vihar University","ror":"https://ror.org/048q3sh29","country_code":"IN","type":"education","lineage":["https://openalex.org/I91894341"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Ashish Kumar Sharma","raw_affiliation_strings":["Department of Pharmacology, Suresh Gyan Vihar University, Mahal, Jagatpura, Jaipur, Rajasthan, Pincode 302025, India. ashishksharma2003@yahoo.com","Department of Pharmacology, Suresh Gyan Vihar University, Mahal, Jagatpura, Jaipur, Rajasthan, Pincode 302025, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Suresh Gyan Vihar University, Mahal, Jagatpura, Jaipur, Rajasthan, Pincode 302025, India. ashishksharma2003@yahoo.com","institution_ids":["https://openalex.org/I91894341"]},{"raw_affiliation_string":"Department of Pharmacology, Suresh Gyan Vihar University, Mahal, Jagatpura, Jaipur, Rajasthan, Pincode 302025, India","institution_ids":["https://openalex.org/I91894341"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111802182","display_name":"B.P. Srinivasan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I39238937","display_name":"Delhi Pharmaceutical Science and Research University","ror":"https://ror.org/022akpv96","country_code":"IN","type":"education","lineage":["https://openalex.org/I39238937"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"B.P. Srinivasan","raw_affiliation_strings":["Department of Pharmacology, Delhi Institute of Pharmaceutical Sciences & Research, Pushpvihar, Sector-III, New Delhi, Pincode 110017, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Delhi Institute of Pharmaceutical Sciences & Research, Pushpvihar, Sector-III, New Delhi, Pincode 110017, India","institution_ids":["https://openalex.org/I39238937"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5030922510"],"corresponding_institution_ids":["https://openalex.org/I91894341"],"apc_list":{"value":3070,"currency":"USD","value_usd":3070},"apc_paid":null,"fwci":2.9659,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.91004362,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"38","issue":"5","first_page":"433","last_page":"444"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9829000234603882,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8709999918937683},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.9959999918937683},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.8130000233650208},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":1.0},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.9380000233650208},{"id":"https://openalex.org/keywords/diabetic-cardiomyopathy","display_name":"diabetic cardiomyopathy","score":0.972000002861023},{"id":"https://openalex.org/keywords/cardiovascular-risk-markers","display_name":"cardiovascular risk markers","score":0.9919999837875366},{"id":"https://openalex.org/keywords/insulin-sensitivity","display_name":"insulin sensitivity","score":0.7929999828338623},{"id":"https://openalex.org/keywords/streptozotocin-induced-diabetes","display_name":"streptozotocin-induced diabetes","score":0.9309999942779541},{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9120000004768372},{"id":"https://openalex.org/keywords/adiponectin","display_name":"adiponectin","score":1.0},{"id":"https://openalex.org/keywords/inflammatory-markers","display_name":"inflammatory markers","score":0.7360000014305115},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.5759999752044678},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.9569903612136841},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.889215350151062},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8515305519104004},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.7859391570091248},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7292779088020325},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.6995398998260498},{"id":"https://openalex.org/C2776782570","wikidata":"https://www.wikidata.org/wiki/Q357439","display_name":"Adiponectin","level":4,"score":0.6161392331123352},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6140276789665222},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.6102005839347839},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5625140070915222},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5258158445358276},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5162034630775452},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.47398248314857483},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4684063792228699},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.4359322488307953},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4144185483455658}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009202","descriptor_name":"Cardiomyopathies","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.ejps.2009.09.004","doi":"https://doi.org/10.1016/j.ejps.2009.09.004","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.ejps.2009.09.004","pdf_url":null,"source":{"id":"https://openalex.org/S119477091","display_name":"European Journal of Pharmaceutical Sciences","issn_l":"0928-0987","issn":["0928-0987","1879-0720"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","doyens","jufo-3","ki-jl-2","medline","norway-2","oarl","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:19765654","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19765654","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308380","display_name":"Yale University","ror":"https://ror.org/03v76x132"},{"id":"https://openalex.org/F4320320736","display_name":"All India Council for Technical Education","ror":"https://ror.org/00xcd7y72"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":48,"referenced_works":["https://openalex.org/W174705705","https://openalex.org/W1968973887","https://openalex.org/W1970161046","https://openalex.org/W1970733045","https://openalex.org/W1971087138","https://openalex.org/W1975588287","https://openalex.org/W1977188464","https://openalex.org/W1980660426","https://openalex.org/W1982990554","https://openalex.org/W1994269792","https://openalex.org/W1999571240","https://openalex.org/W2008288517","https://openalex.org/W2013253832","https://openalex.org/W2014971826","https://openalex.org/W2015503000","https://openalex.org/W2016183600","https://openalex.org/W2018176172","https://openalex.org/W2043856487","https://openalex.org/W2046264850","https://openalex.org/W2050018002","https://openalex.org/W2052013968","https://openalex.org/W2054041854","https://openalex.org/W2061280991","https://openalex.org/W2082049752","https://openalex.org/W2085516085","https://openalex.org/W2094394439","https://openalex.org/W2102469433","https://openalex.org/W2102675827","https://openalex.org/W2105912552","https://openalex.org/W2107529930","https://openalex.org/W2119321610","https://openalex.org/W2126521413","https://openalex.org/W2127066946","https://openalex.org/W2143991719","https://openalex.org/W2146354558","https://openalex.org/W2149077676","https://openalex.org/W2153376178","https://openalex.org/W2157604930","https://openalex.org/W2159969745","https://openalex.org/W2160234571","https://openalex.org/W2160638574","https://openalex.org/W2162702313","https://openalex.org/W2164367541","https://openalex.org/W2165509099","https://openalex.org/W2398113239","https://openalex.org/W4241471955","https://openalex.org/W4251863399","https://openalex.org/W6712546880"],"related_works":["https://openalex.org/W1487783739","https://openalex.org/W2083147531","https://openalex.org/W2416383621","https://openalex.org/W2908000452","https://openalex.org/W4414435068","https://openalex.org/W2139869385","https://openalex.org/W3029448397","https://openalex.org/W2035838062","https://openalex.org/W2362344741","https://openalex.org/W1915448748"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}